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betes has a negative impact on functioning as measured
by engagement in productive activities.
PMH52
PATIENT-VALUED HEALTH STATE UTILITIES
FOR BIPOLAR DISORDER: DIFFERENCES THAT
CAN BE MEASURED
Hanlon JT1, Mannix S1, Kleinman L1, Martin S2, Revicki D1
1MEDTAP International, Inc, Bethesda, MD, USA; 2J&J
Pharmaceuticals Services, L.L.C, Raritan, NJ, USA
OBJECTIVE: Patients with bipolar disorder experience
problems with functioning and well-being, or health
related quality of life (HRQL). Utilities, reﬂecting the
impact of psychopathology and treatment on patient
HRQL, are needed to estimate outcomes in economic
evaluations. Our objective was to elicit utility scores for
health states associated with bipolar disorder and side-
effects of treatment. METHODS: Patients with a DSM-
IV deﬁned diagnosis of Bipolar I Disorder who were
currently stable, but had experienced two previous manic
or mixed episodes in the last ﬁve years, were recruited
and interviewed at three clinical research sites in the US.
Health states used in the interview were derived from lit-
erature, clinical experience and clinical trial data. They
included attributes of clinical psychopathology (stable,
mania or major depression), HRQL (physical, social, and
role functioning), treatment-related side effects, and treat-
ment setting (inpatient or outpatient). In a one-time stan-
dard gamble interview, each patient valued a subset of the
total number of health states. RESULTS: Inpatient mania
mean utility scores for moderate severity, ranged from
0.14 (S.D. 0.20) to 0.37 (S.D. 0.33) and for mild sever-
ity, utility scores ranged from 0.13 (S.D. 0.16) to 0.83
(S.D. 0.21). Utility scores for outpatient mania, moderate
severity, ranged from 0.15 (S.D. 0.19) to 0.60 (S.D. 0.07)
and for mild severity scores ranged from 0.79 (S.D. 0.11)
to 0.36 (S.D. 0.16). Stable state scores ranged from 0.36
(S.D. 0.16) to 0.95 (S.D. 0.00) and depression was 0.30
(S.D. 0.33). Treatment related side-effects appear to
decrease patient utilities and have a larger impact in stable
states. CONCLUSIONS: Health state utility scores can be
obtained from patients with bipolar disorder. The utility
scores provided by patients for hypothetical states
demonstrate differences by disease severity and treatment.
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IMPACT OF WEIGHT GAIN ON HEALTH-
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OBJECTIVES: To determine whether patients with
bipolar disorder with weight gain have different HRQL
than those without weight gain. METHODS: In June
2001, 573 persons reported being diagnosed with bipolar
disorder on a self-administered questionnaire. Of these,
377 provided information on their weight gains or losses
during the past six months. A cross-sectional comparison
of the HRQL among patients with bipolar disorder who
gained weight and those who did not was performed.
Weight gain was deﬁned as gaining six or more pounds
(2.73Kg) over the past six months. HRQL was measured
using two validated scales, the Psychological General
Well-Being scale (PGWB) and the SF-8. RESULTS: Out
of 377 patients included in the analysis, 168 (44.6%)
reported weight gain. Patients who reported weight gain
had signiﬁcantly lower mean PGWB scores, 47.4 (SD =
21.9) vs. 53.2 (SD = 23.6) p = 0.015 and lower scores on
Anxiety, Self-Control and Vitality subscales compared to
those without weight gain. Patients with weight gain had
statistically lower scores in the mental health summary
scale, and the role emotional and mental health domains
of the SF-8. CONCLUSION: Patients with bipolar dis-
order and weight gain appear to have a lower HRQL
compared to patients without weight gain.
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OBJECTIVES: Comorbid mental health conditions are
common and associated with poor health outcomes in the
U.S. population. The purpose of this study is to examine
the prevalence and patterns of mental health comorbid-
ity and whether comorbidity inﬂuences quality of life
ratings in a sample of Gulf War military personnel.
METHODS: The Iowa Gulf War Study Case Validation
study conducted face-to-face evaluations of 602 military
personnel either deployed or eligible but not deployed to
the Persian Gulf War (PGW) in 1999–2002 to estimate
the magnitude of health problems encountered by the
PGW deployed. The subjects were sampled by conduct-
ing a series of case-control studies nested within a popu-
lation-based survey of 4886 military personnel (JAMA,
1997). Mental health comorbidity consisted of endorsing
two or more mental disorders. We used the Health Util-
ities Index (HUI) to measure health-related quality of life
(HRQoL). RESULTS: One hundred ninety-three (32%)
of the 602 surveyed veterans had a current mental disor-
der. Slightly over 11% (n = 69) had a comorbid mental
disorder. The most common patterns of comorbidity were
co-occurring depressive and anxiety disorders, followed
by co-occurring substance use, depressive, and anxiety
disorders. Those with mental health comorbidity had
lower HUI scores than veterans without mental health
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comorbidity (mean 0.41 +/- 0.30 vs. 0.72 +/- 0.25, p <
0.0001). In multivariate analyses, comorbidity remained
signiﬁcantly associated with HUI, even after controlling
for age, sex, case status, and deployment. CONCLU-
SIONS: Mental health comorbidity is common among
veteran populations. Its patterns resemble those found in
the general U.S. population. Mental health comorbidity
is strongly related to decreased quality of life among 
military veterans. Improvements in diagnosis and treat-
ment of mental health comorbidity may lead to enhanced
HRQoL.
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OBJECTIVES: Debate continues regarding the stability of
preferences across time and illness. The purpose therefore
was to determine if the experience of depressive disorder
changes patients’ risk attitudes and elasticity for time,
components of their standard gamble (SG) and time
trade-off (TTO) utilities. This study tests the explanatory
power of the Medical Care System Access Framework for
depression experience impact on patient preferences while
controlling for patient population characteristics.
METHODS: This study used two years of data from Part-
ners in Care, a group-level randomized controlled trial of
quality improvement programs for depression. For 1218
primary care patients with depression, we examined
single-item SG and TTO utilities at baseline and 24
months. Logistic regressions identiﬁed factors associated
with patients’ willingness to take risks and trade time 
and examined trends in utilities of individuals with and
without remission of depression as measured by the
Center for Epidemiologic Studies Depression screener and
the World Health Organization Composite International
Diagnostic Instrument. RESULTS: A dose-response gra-
dient indicating greater willingness to take risks or trade
time was found as depression increased. Patients who
continued to be depressed at 24 months were nearly 3
times more likely to be willing to assume risk or trade
time than patients whose depression remitted. Willingness
to assume risk or trade time increased in patients who
continued to be depressed at 24 months. However the SG
appeared to lack sensitivity in patients whose depression
remitted. Remission of depression was associated with a
decrease in willingness to trade time as expected and a
paradoxical increase in willingness to assume risk. CON-
CLUSIONS: Patients with depression appear to use a
single-item SG measure differently at baseline and 24
months. This could be due to changes in risk attitude
resulting from health experiences. Changes in values may
confound the use of single-item SG utilities as measures
of outcomes.
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OBJECTIVES: This analysis was designed to character-
ize longitudinal changes in quality of life in adults receiv-
ing publicly-funded treatment for substance use disorders.
METHODS: Clients were randomly sampled from 13
Massachusetts facilities providing publicly-funded deto-
xiﬁcation and outpatient drug treatment services. A total
of 206 adult clients completed an in-person baseline inter-
view and follow-up telephone interviews 1 year and 3
years later. Quality of life (QOL) was measured by the
SF-12 Physical Component Score (PCS) and Mental Com-
ponent Score (MCS). Latent growth modeling was used
to estimate the effects of ﬁve factors—age, gender, detox
status, managed care status, and drug treatment ser-
vices—on QOL trajectories over time. RESULTS: Seventy
percent of the clients were recruited from detoxiﬁcation
facilities, 52% were males, 52% were enrolled in Medic-
aid managed care plans, and 50% received drug treat-
ment services during the year prior to the last interview.
The growth models provided excellent ﬁts for both tra-
jectories. MCS scores increased from 31.0 at baseline to
38.9 at the time of the one year follow-up and remained
stable at year 3 (39.0). Clients recruited from detox
centers had signiﬁcantly lower MCS scores at baseline
and much higher slopes over time. The MCS trends were
essentially ﬂat for outpatients. The mean PCS score
increased from 43.6 to 46.1 after 1 year but then declined
back to 43.0 by the time of the 3-year follow-up. Base-
line physical functioning was negatively correlated with
client age and managed care status. PCS slopes declined
more rapidly for older clients than for younger respon-
dents. CONCLUSIONS: The results indicate that emo-
tional well-being for substance abusers improves after one
year and that this gain is maintained over the next two
years. Physical functioning rises and then falls. Managed
care and drug treatment during the intervening period
had little impact on QOL trajectories.
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SYMPTOMATOLOGY: FRENCH RESULTS
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OBJECTIVE: To evaluate the effect of psoriasis on
quality of life of patients and -DS- in France. To highlight
a relation between DS and quality of life for patients suf-
fering from psoriasis. METHOD: Seven hundred ﬁfty
anonymous questionnaires (comprised 2 scales: the Pso-
riasis Disability Index [PDI] and the Center for Epidemi-
ologic Studies—Depression scale [CES-D] were sent, via
